INSM Q3 2022 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$68M+44.9% YoY

Gross Profit

$54M80.1% margin

Operating Income

-$128M-188.5% margin

Net Income

-$131M-193.6% margin

EPS (Diluted)

$-1.09

QoQ Revenue Growth

+3.8%

Cash Flow

Operating Cash Flow

-$90M

Free Cash Flow

-$90M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$995M

Total Liabilities

$1.0B

Stockholders' Equity

-$30M

Cash & Equivalents

$415M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68M	$47M	+44.9%
Gross Profit	$54M	$37M	+48.4%
Operating Income	-$128M	-$104M	-23.2%
Net Income	-$131M	-$113M	-16.4%

Geographic Segments

UNITED STATES

$50M73%

JAPAN

$14M21%

Europe And The Rest Of The World

$4M5%